Psichiatria

"Rapid Reference to Schizophrenia" will provide the reader with authoritative and accessible information from a clinical expert in the field, to assist with treatment decisions. Each title in the new "Rapid Reference Series" provides standard core content (epidemiology - management/ therapy) combined with the additional information, such as FAQs and patient organisations, needed by the GP to provide effective patient care. They also include drugs listings, clinical trials, information on future developments and web site listings to keep the reader up to speed with new developments and to extend their knowledge of the disease area. With patients becoming better informed about the nature and management of their conditions, "Rapid Reference" is a timely new series that offer GPs easy access to the best information for patient care and management.

Sono raccolti in questo volume alcuni lavori scelti dall'Autore pubblicati su trattati, libri o riviste nel corso degli anni c

In the ongoing quest to improve our psychiatric diagnostic system, we are now searching for new approaches to understanding the etiological and pathophysiological mechanisms that can improve the validity of our diagnoses and the consequent power of our preventive and treatment interventionsAventuring beyond the current DSM paradigm and DSM-IV framework. This thought-provoking volumeAproduced as a partnership between the American Psychiatric Association, the National Institute of Mental Health, the National Institute on Alcohol Abuse and Alcoholism, and the National Institute on Drug AbuseArepresents a far-reaching attempt to stimulate research and discussion in the field in preparation for the eventual start of the DSM-V process, still several years hence. The book -Explores a variety of basic nomenclature issues, including the desirability of rating the quality and quantity of information available to support the different disorders in the DSM in order to indicate the disparity of empirical support across the diagnostic system. -Offers a neuroscience research agenda to guide development of a pathophysiologically based classification for DSM-V, which reviews genetic, brain imaging, postmortem, and animal model research and includes strategic insights for a new research agenda. -Presents highlights of recent progress in developmental neuroscience, genetics, psychology, psychopathology, and epidemiology, using a bioecological perspective to focus on the first two decades of life, when rapid changes in behavior, emotion and cognition occur. -Discusses how to address two important gaps in the current DSM-IV: (1) the categorical method of diagnosing personality disorders and their relationship with Axis I disorders, and (2) the limited provision for the diagnosis of relational disordersAsuggesting a research agenda for personality disorders that considers replacing the current categorical approach with a dimensional classification of personality. -Reevaluates the relationship between mental disorders and disability, asserting that research into disability and impairment would benefit from the diagnosis of mental disorders be uncoupled from a requirement for impairment or disability to foster a more vigorous research agenda on the etiologies, courses, and treatment of mental disorders as well as disabilities and to avert unintended consequences of delayed diagnosis and treatment. -Examines the importance of culture in psychopathology and the main cultural variables at play in the diagnostic process, stating that training present and future professionals in the need to include cultural factors in the diagnostic process is a logical step in any attempt to develop comprehensive research programs in psychology, psychiatry, and related disciplines. This fascinating work, with contributions from an international group of research investigators, reaches into the core of psychiatry, providing invaluable background and insights for all psychology and psychiatry professionalsAfood for thought and further research that will be relevant for years to come.

This is a thoroughly revised and updated edition of the definitive text on electroconvulsive therapy. This essential resource remains the primary reference and guide for those who prescribe, perform, or assist with ECT. New material for this edition includes coverage of the recently published 3rd edition of the American Psychiatric Association's Task Force Report on ECT (which lays out the boundaries within which ECT should be administered in the United States) and a new chapter on transcranial magnetic stimulation (rTMS), a treatment method that is analogous to ECT.

Written by leading authorities in psychiatry, this volume addresses a wide range of clinically relevant issues in the psychiatric evaluation and treatment of women. Coverage includes conditions unique to womenusuch as premenstrual dysphoric disorder, postpartum depression, and perimenopause-related depressionuand gender differences in the clinical presentation and treatment response of mood, anxiety, psychotic, and substance use disorders. Included is a discussion of behavioral inhibition in girls and how this can increase women's vulnerability to anxiety disorders. Other chapters focus on eating disorders, body dysmorphic disorder, borderline personality disorder, attention deficit hyperactivity disorder in girls, and depression and anxiety associated with in vitro fertilization

Psychiatry in Society provides an overview of the recent socio-economic and cultural changes affecting mental health and mental health care. These changes include: The increasing complexity of the economic contexts within which mental health services are funded and delivered The demand for cost-effectiveness evidence The rationing of access to new pharmacotherapies and psychotherapies The emergence of quality of life as an essential criterion in the assessment of health care interventions The growing awareness of the influence of stigma on shaping the long-term course of severe mental disorders The enhanced role of advocacy groups in providing information, advice and support to sufferers This book will be of interest to psychiatrists and psychologists, mental health workers, managers and policy makers.

Contains guidelines and recommendations-in tabular form for quick reference-on patient evaluation and optimal treatment for long-term care! Based on evidence from recent systematic clinical research studies, this comprehensive reference provides the latest information on the assessment, diagnosis, and treatment of schizophrenia-highlighting modern diagnostic tools and current therapeutic advances for the prevention of hallucinations, thought disorganization, and negative symptoms. Emphasizes family education and psychoeducation, and community-centered treatments for patient rehabilitation and adherence to management programs! With consideration of the chronic nature of the disease, Schizophrenia details * the effect of substance abuse and drug dependence on rehabilitation and treatment * second-generation antipsychotic drugs, including olanzapine, quetiapine, risperiodone, and ziprasidone * contemporary strategies to prevent depression and suicide * patterns of patient compliance and noncompliance * violence and forensic hospitalization With over 600 useful references, Schizophrenia is an essential source for psychiatrists and psychopharmacologists, clinical neurologists and neuropsychopharmacologists, psychologists, primary care physicians, social workers, nurses, and graduate and medical school students in these disciplines.

Il volume offre un'analisi approfondita e dettagliata del suicidio, un fenomeno di non semplice definizione, del quale si va acquisendo tuttavia una sempre più chiara coscienza scientifica, sia per quanto riguarda i suoi aspetti psicologici e neurobiologici, sia in relazione al complesso interscambio con il substrato sociale che concorre a determinarne le caratteristiche e l'espressione. Gli autori, esperti di fama internazionale, evidenziano la natura multidisciplinare del suicidio, descrivendolo da una prospettiva epidemiologica, psicopatologica e strettamente psicobiologica (biochimica, neuroenaocrmologica, genetica) nelle diverse età della vita e in differenti condizioni ambientali. La riflessione su questi temi ha condotto all'elaborazione di protocolli di gestione, valutazione e trattamento che hanno l'obiettivo di intervenire in modo puntuale ed efficace sui pazienti con condotte suicidarie.